Silver Grove Financial Group »

Bioxcel Therapeutics shares owned by Silver Grove Financial Group

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Silver Grove Financial Group from 13F filings

Historical chart of Silver Grove Financial Group investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Silver Grove Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Silver Grove Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $446 334 1.34

More positions owned by Silver Grove Financial Group

Main Sector MF Closed and MF Open (SECT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Advisors Inner Circle Fd Ii 3edge Dynamic Fi (EDGF)
Ishares Tr Core Us Aggbd Et (AGG)
Nvidia Corp Common Stock (NVDA)
Apple (AAPL)
Invesco Qqq MF Closed and MF Open (QQQ)
Microsoft Corporation (MSFT)
Amazon Common Stock (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Jpmorgan Chase Common Stock (JPM)
Broadcom (AVGO)
Ishares Tr National Mun Etf (MUB)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Silver Grove Financial Group

Top funds holding Bioxcel Therapeutics

Millennium Management
Armistice Capital
Vanguard Group
Oaktree Capital Management
Geode Capital Management
Vanguard Capital Management
Jones Financial Companies, L.L
Man Group
FMR
Vanguard Fiduciary Trust
BlackRock
State Street Corporation
UBS Group
Oaktree Fund Advisors
HighTower Advisors

View all funds holding Bioxcel Therapeutics